Long COVID Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are a staff member at the NIH (National Institutes of Health) at the time of joining the study
- You are 18 years of age or older
- You are able to understand and agree to participate in the study on your own
- You are planning to get this year's flu vaccine and/or a COVID-19 vaccine that has been approved or authorized by the FDA
- You are willing and able to have blood drawn (either at a clinic or at home using a home sampling kit) and to provide nasal samples
- You are willing and able to have at least one blood draw and one nasal sample taken before receiving your vaccine
Who may not be able to join:
- You have already received this year's flu vaccine and you do not plan to get an FDA-approved or authorized COVID-19 vaccine
- You have already received an FDA-approved or authorized COVID-19 vaccine and you do not plan to get this year's flu vaccine
- You are not willing to receive either this year's flu vaccine or an FDA-approved or authorized COVID-19 vaccine
- You have any health condition that the study doctor believes would make it unsafe or unsuitable for you to participate (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Alison Han, M.D., National Institute of Allergy and Infectious Diseases (NIAID)
Phone: Not Listed
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Systemic anti-SARS-CoV-2 antibodies; Systemic anti-influenza antibodies
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.